Short-run, small window drug manufacture at the clinical research unit (CRU).

A guide to successful planning and execution

Combined advanced therapy medicinal products: European regulatory requirements, pathways and processes

Key chemistry, manufacturing, and controls strategies for the development of cell and gene therapies

Regulatory strategy considerations for advanced therapies

Practical considerations for cell and gene therapy trials in neonates and young children living with rare diseases

Finding the optimal dose in Project Optimus: Understanding your oncology asset and defining your possibilities

The hidden crisis in early-phase cancer trials: A challenge to be bold, creative and fearless

Why the UK Is Now a Strategic Hub for Early Clinical Trials.

As we manage the conduct of your complex study, we never take our eyes off the two critical focal points—scientific integrity and human subject safety.

Strengthening our commitment to sustainability at the Leeds Drapers Yard Clinical Research Unit (CRU)